A Comparison between Therapeutic Effect of Granulocyte Colony-stimulating Factor and Methylprednisolone in Treatment of Patients with Acute Traumatic Spinal Cord Injury

Background & Aim: Spinal cord injury (SCI) is one of the worst kinds of traumatic injuries with remarkable social and economiceffects on communities.Methods & Materials/Patients: In this prospective randomized clinical trial, 122 patients with traumatic spinal cord injury wereadmitted to Poursina hospital within 48 hours of injury to compare granulocyte colony stimulating factor (G-CSF) and high-dosemethylprednisolone as neuroprotective therapy.Results: In this research, 122 patients were studied out of whom 62 patients were included in the granulociote colony-stimulatingfactor (G-CSF) group with a mean age of 40.4, and 60 patients in the methylprednisolone group with an average age of 40.10 years.55 out of 122 patients (45%) were completely paralyzed (Grade AIS:A) and 67 (55%) were with incomplete spinal injury (GradeAIS:B,C,D). The average American spinal injury association (ASIA) sensory scores in the two groups were similarly compared inthe same four time intervals, and p values were 0.7, 0.3, 0.2, and 0.1. They were not statistically significant.Conclusion: According to the results, the G-CSF was shown to be beneficial in average ASIA motor and sensory scores in the twogroups of male patients at six months of onset of G-CSF treatment (p value=0.04), and average ASIA motor scores improvement inthe falls subgroup patients also differed significantly within six months of onset of G-CSF treatment (p value=0.03). A multicentreprospective randomized clinical trial to compare the placebo effect with G-CSF protocol s treatment, and also assessment of thecost benefits of the common medical treatment versus G-CSF are n eeded.

کلیدواژه ها:

Granulocyte ، Colony-stimulating ، Methylprednisolone ، Treatment